SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000175
Filing Date
2021-08-09
Accepted
2021-08-09 07:00:22
Documents
20
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20210809.htm   iXBRL 8-K 43478
2 EX-99.1 a2q2021earningspressrele.htm EX-99.1 20539
6 GRAPHIC a2q2021earningspressrele001.jpg GRAPHIC 243426
7 GRAPHIC a2q2021earningspressrele002.jpg GRAPHIC 304086
8 GRAPHIC a2q2021earningspressrele003.jpg GRAPHIC 313927
9 GRAPHIC a2q2021earningspressrele004.jpg GRAPHIC 346553
10 GRAPHIC a2q2021earningspressrele005.jpg GRAPHIC 304031
11 GRAPHIC a2q2021earningspressrele006.jpg GRAPHIC 136420
12 GRAPHIC a2q2021earningspressrele007.jpg GRAPHIC 93565
  Complete submission text file 0001485003-21-000175.txt   2615198

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210809.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210809_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210809_pre.xml EX-101.PRE 13190
13 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210809_htm.xml XML 11729
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211154548
SIC: 2834 Pharmaceutical Preparations